The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 31, 2019
Filed:
Oct. 22, 2015
Applicant:
Ngm Biopharmaceuticals, Inc., South San Francisco, CA (US);
Inventors:
Darrin Anthony Lindhout, Mountain View, CA (US);
Charles V. Olson, Moraga, CA (US);
Assignee:
NGM Biopharmaceuticals, Inc., South San Francisco, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/18 (2006.01); C07K 14/50 (2006.01); A61K 9/08 (2006.01); A61K 47/18 (2017.01); A61K 47/26 (2006.01); A61K 9/19 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1825 (2013.01); A61K 9/08 (2013.01); A61K 47/18 (2013.01); A61K 47/26 (2013.01); C07K 14/50 (2013.01); A61K 9/19 (2013.01); C07K 2319/00 (2013.01);
Abstract
Provided herein are pharmaceutical compositions, formulations and dosage forms comprising variants of fibroblast growth factor 19 (FGF19) proteins and peptide sequences (and peptidomimetics) and fusions of FGF19 and/or fibroblast growth factor 21 (FGF21) proteins and peptide sequences (and peptidomimetics), and variants of fusions of FGF19 and/or FGF21 proteins and peptide sequences (and peptidomimetics). Methods of using the pharmaceutical compositions, formulations and dosage forms are also provided herein.